Smriti Kundu‐Raychaudhuri

K252a, a High-Affinity Nerve Growth Factor Receptor Blocker, Improves Psoriasis: An In Vivo Study Using the Severe Combined Immunodeficient Mouse–Human Skin Model

S. P. Raychaudhuri, Mrinmoy Sanyal, Helena Weltman et al. · Journal of Investigative Dermatology · 2004 · 96 citations · Full text

Inflammation, Cutaneous Biology, Immunology +7

IL-9, a local growth factor for synovial T cells in inflammatory arthritis

Smriti Kundu‐Raychaudhuri, Christine Abria, S. P. Raychaudhuri · Cytokine · 2016 · 74 citations

Inflammation, Rheumatology, Rheumatoid Disorder +12

Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis – Xenograft model

Smriti Kundu‐Raychaudhuri, Yi‐Je Chen, Heike Wulff et al. · Journal of Autoimmunity · 2014 · 69 citations · Full text

Medicine, Immunology, Clinical Dermatology +7

1α,25-Dihydroxyvitamin-D3-3-Bromoacetate Regulates AKT/mTOR Signaling Cascades: A Therapeutic Agent for Psoriasis

Ananya Datta Mitra, S. P. Raychaudhuri, Christine Abria et al. · Journal of Investigative Dermatology · 2013 · 50 citations · Full text

Inflammation, Anti-inflammatory, Medicine +7

FR255734, a Humanized, Fc-Silent, Anti-CD28 Antibody, Improves Psoriasis in the SCID Mouse-Psoriasis Xenograft Model

S. P. Raychaudhuri, Smriti Kundu‐Raychaudhuri, Kouichi Tamura et al. · Journal of Investigative Dermatology · 2008 · 37 citations · Full text

Autoimmune Disease, Anti-cd28 Antibody, Cutaneous Biology +7